title: Portal vein thrombosis secondary to embolization of superior mesenteric arteriovenous fistula.
abstract: Superior mesenteric arteriovenous fistula is a rare vascular disorder. Endovascular embolization has been widely used to treat this disease. Patients receiving successful fistula embolization generally have good prognoses. We present a man with iatrogenic superior mesenteric arteriovenous fistula who received endovascular embolization. Portal thrombus was detected on postoperative day 2, and the patient eventually died of multiple organ failure on postoperative day 13 despite having received antithrombotic and antiplatelet therapy. We identified portal thrombosis as a serious complication of transcatheter superior mesenteric arteriovenous fistula embolization.
authors.affiliation: Division of Nephrology, West China Hospital of Sichuan University, Sichuan, Chengdu, China.
authors.forename: Yuliang
authors.initials: Y
authors.lastname: Zhao
authors.affiliation: Division of Radiology, West China Hospital of Sichuan University, Sichuan, Chengdu, China.
authors.forename: Zhengyan
authors.initials: Z
authors.lastname: Li
authors.affiliation: Division of Nephrology, West China Hospital of Sichuan University, Sichuan, Chengdu, China.
authors.forename: Ling
authors.initials: L
authors.lastname: Zhang
authors.affiliation: Division of Gastroenterology, West China Hospital of Sichuan University, Sichuan, Chengdu, China.
authors.forename: Bo
authors.initials: B
authors.lastname: Wei
authors.affiliation: Division of Nephrology, West China Hospital of Sichuan University, Sichuan, Chengdu, China.
authors.forename: Xiaoxi
authors.initials: X
authors.lastname: Zeng
authors.affiliation: Division of Nephrology, West China Hospital of Sichuan University, Sichuan, Chengdu, China. Electronic address: fupinghx@163.com.
authors.forename: Ping
authors.initials: P
authors.lastname: Fu
mesh_terms: D001164:Arteriovenous Fistula / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D017809:Fatal Outcome; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D017538:Mesenteric Artery, Superior / Q000000981:diagnostic imaging / Q000293:injuries; D008642:Mesenteric Veins / Q000000981:diagnostic imaging / Q000293:injuries; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology; D010690:Phlebography / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011169:Portal Vein; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors